🕒 Tuesday 29 July 2025 Tue, 29 July 2025

Imagion Biosystems has made significant progress towards filing an Investigational New Drug application for its MagSense® HER2 breast cancer imaging agent, receiving encouraging feedback from the FDA and preparing for a Phase 2 clinical trial.

Bastion Mining has taken control of over 90% of Xanadu Mines shares through a takeover bid, moving swiftly to compulsory acquisition and setting the stage for the Kharmagtai project’s next phase.

Perenti Limited’s underground mining subsidiary Barminco has been hit with a $46 million legal claim from MMG Dugald River Pty Ltd related to a completed contract at the Dugald River Mine. Barminco denies liability and plans to vigorously defend the case while pursuing a counterclaim.

Paradigm Biopharmaceuticals has advanced its global Phase 3 trial for knee osteoarthritis pain with active patient recruitment in Australia and the US, backed by a $41.2 million convertible note facility. The company also expanded its osteoarthritis portfolio through the acquisition of Proteobioactives and the Pentacoxib™ oral therapy.

Global Uranium and Enrichment Limited’s investee Ubaryon has sealed a binding agreement with uranium giant Urenco, unlocking a A$5 million investment and technical collaboration to accelerate a novel uranium enrichment technology.

OpenLearning Limited reported a robust Q2 FY25 with 22% year-on-year SaaS ARR growth to $2.65 million, driven by significant multi-year contract wins and expanding global customer base. The company’s AI-powered LMS strategy is delivering larger deals and improved cash flow metrics.

Iondrive Limited advances its proprietary battery recycling technology with a pilot plant design, European consortium formation, and new e-waste initiatives, supported by significant grant funding.

Andean Silver Limited reports a significant 22% increase in silver equivalent ounces at its Cerro Bayo project, alongside progress on a production restart study and a successful A$30 million capital raise.

Aguia Resources has reported promising initial diamond drilling results at its Santa Barbara gold project in Colombia, confirming high-grade gold mineralisation continuity beneath existing underground workings. The ongoing drilling program aims to delineate an extensive mineralised vein system with further assay results expected soon.

QPM Energy has successfully completed major commissioning runs at its Townsville Power Station, generating over 4,700 MWh and preparing to take operational control. Final steps are underway to leverage new gas agreements and electricity market opportunities.

Bannerman Energy reports robust progress on its Etango Uranium Project, achieving key construction milestones and securing A$85 million in fresh equity to fuel its path to a Final Investment Decision.

Brazilian Rare Earths Limited (BRE) confirms Sulista West as an ultra high-grade rare earth project with exceptional drill results and reports metallurgical breakthroughs at Monte Alto, underpinning its integrated supply chain ambitions.

Strickland Metals reports robust drilling results at its Serbian Rogozna Project, confirming significant gold and base metal mineralisation, while securing a $45 million equity deal for its Yandal Project in Western Australia.

Bannerman Energy reported a robust $80 million cash inflow from financing in Q2 2025, offsetting significant exploration expenditures and maintaining a strong cash position.

Cavalier Resources progresses its Crawford Gold Project with key milestones including an $11 million stream finance negotiation with Raptor Capital and the appointment of Colin Bald as General Manager of Operations.

Black Dragon Gold has entered a critical public consultation phase for its Salave Gold Project’s land use change, marking a key step in its strategic project application amid local government opposition and strong community backing.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.

Avecho Biotechnology reports strong progress in its Phase III clinical trial for a CBD-based insomnia treatment, with recruitment accelerating across multiple Australian sites and interim results expected early next year.

Arafura Rare Earths pushes forward with equity funding for its Nolans Project, targeting a €100 million investment from Germany’s Raw Materials Fund amid rising geopolitical tensions reshaping the rare earths landscape.

Patagonia Lithium Ltd has announced a fully underwritten entitlement offer to raise approximately $2.68 million, aimed at advancing its drilling program in Argentina and updating its mineral resource estimates. The offer, supported by major shareholders, reflects confidence in the company’s Formentera Lithium Brine Project.

Iltani Resources has delivered robust drilling results at its Orient Silver-Indium Project, reinforcing its status as a leading silver-indium discovery in Australia, while securing nearly $3 million to advance exploration.

Tigers Realm Coal’s planned sale of its Russian subsidiaries faces significant delays and a pricing impasse, with regulatory hurdles and sanctions complicating the exit process and triggering an ASX trading suspension.

Anatara Lifesciences reports Phase II GaRP-IBS trial results showing no safety concerns but missing the primary efficacy endpoint, while securing key patents and receiving a significant R&D tax refund.

Nimy Resources has reported exceptional high-grade gallium results from its Block 3 drilling campaign in Western Australia, setting the stage for a maiden JORC resource estimate in the coming quarter.